Health care providers' perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022-2023).

IF 4.2 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Human Vaccines & Immunotherapeutics Pub Date : 2026-12-01 Epub Date: 2026-10-05 DOI:10.1080/21645515.2026.2734052
Rida A Khatri, Gregory D Zimet, Monica L Kasting, Katharine J Head
{"title":"Health care providers' perspectives on county-level barriers and facilitators to HPV vaccination: A socio-ecological approach (2022-2023).","authors":"Rida A Khatri, Gregory D Zimet, Monica L Kasting, Katharine J Head","doi":"10.1080/21645515.2026.2734052","DOIUrl":null,"url":null,"abstract":"<p><p>In Indiana, HPV vaccine series completion is 59.6%. Using a socio-ecological model (SEM) approach, this study investigates county health department providers' perspectives on improving vaccine initiation and completion among adolescents in Indiana. We conducted semi-structured interviews to explore health department providers' opinions on barriers and facilitators of HPV vaccine series initiation and completion amongst parents of adolescents. Thematic analysis was then conducted on the transcribed interviews. Interviews were conducted with 24 county health department providers across Indiana with 54.2% (n = 13) holding a Vaccine Coordinator position. Perceived barriers to initiation at the individual level included the parents' lack of education regarding the HPV vaccine and the importance of prevention. Interpersonally, misinformation and busy schedules for both the parents and adolescents hindered initiation and completion. Further, the presentation of the vaccine by the clinic could affect initiation and completion rates (both positively and negatively). Organizationally, having reminder systems regarding follow-up appointments was a facilitator to completion. Community-level barriers included a lack of providers, transportation, and language issues, but flexible scheduling options were a facilitator. Policy barriers included HPV not being a school-required vaccine. Participants provided valuable insight into perceptions of the HPV vaccine and the barriers and facilitators to HPV vaccine series initiation and completion in Indiana. Barriers to series completion included lack of information and conflicting schedules. Facilitators of series completion included reminder systems and flexible vaccination scheduling options. Interventions that include these facilitators can be developed to improve completion.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"22 1","pages":"2734052"},"PeriodicalIF":4.2000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13644608/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2026.2734052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In Indiana, HPV vaccine series completion is 59.6%. Using a socio-ecological model (SEM) approach, this study investigates county health department providers' perspectives on improving vaccine initiation and completion among adolescents in Indiana. We conducted semi-structured interviews to explore health department providers' opinions on barriers and facilitators of HPV vaccine series initiation and completion amongst parents of adolescents. Thematic analysis was then conducted on the transcribed interviews. Interviews were conducted with 24 county health department providers across Indiana with 54.2% (n = 13) holding a Vaccine Coordinator position. Perceived barriers to initiation at the individual level included the parents' lack of education regarding the HPV vaccine and the importance of prevention. Interpersonally, misinformation and busy schedules for both the parents and adolescents hindered initiation and completion. Further, the presentation of the vaccine by the clinic could affect initiation and completion rates (both positively and negatively). Organizationally, having reminder systems regarding follow-up appointments was a facilitator to completion. Community-level barriers included a lack of providers, transportation, and language issues, but flexible scheduling options were a facilitator. Policy barriers included HPV not being a school-required vaccine. Participants provided valuable insight into perceptions of the HPV vaccine and the barriers and facilitators to HPV vaccine series initiation and completion in Indiana. Barriers to series completion included lack of information and conflicting schedules. Facilitators of series completion included reminder systems and flexible vaccination scheduling options. Interventions that include these facilitators can be developed to improve completion.

卫生保健提供者对县级HPV疫苗接种障碍和促进因素的看法:一种社会生态学方法(2022-2023)。
在印第安纳州,HPV疫苗系列完成率为59.6%。使用社会生态模型(SEM)方法,本研究调查了县卫生部门提供者对改善印第安纳州青少年接种和完成疫苗的观点。我们进行了半结构化访谈,以探讨卫生部门提供者对青少年父母中HPV疫苗系列开始和完成的障碍和促进因素的看法。然后对采访记录进行专题分析。对印第安纳州24个县卫生部门提供者进行了访谈,其中54.2% (n = 13)持有疫苗协调员职位。在个人层面上,开始接种的障碍包括父母缺乏关于HPV疫苗的教育和预防的重要性。在人际关系上,父母和青少年的错误信息和繁忙的日程安排阻碍了开始和完成。此外,诊所提供疫苗可能会影响接种率和完成率(正面和负面影响)。在组织上,关于后续约会的提醒系统有助于完成任务。社区层面的障碍包括缺乏服务提供者、交通和语言问题,但灵活的时间表选择是一个促进因素。政策障碍包括HPV不是学校要求的疫苗。参与者提供了宝贵的见解,对人乳头瘤病毒疫苗的看法和障碍和促进人乳头瘤病毒疫苗系列启动和完成在印第安纳州。完成系列的障碍包括缺乏信息和冲突的时间表。系列完成的促进因素包括提醒系统和灵活的疫苗接种计划选择。可以开发包括这些促进因素的干预措施,以提高完井率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
CiteScore
7.90
自引率
8.30%
发文量
489
审稿时长
3-6 weeks
期刊介绍: (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书